lunes, 7 de septiembre de 2026

Desafiando los límites del riesgo de recurrencia en el cáncer de mama incipiente HR+/HER2− de alto riesgo

Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer Authors: Joyce A. O’Shaughnessy, MD; Priya Rastogi, MD; Seth Wander, MD, PhD https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?page=3&subtitle-lang-code=es&ecd=mkm_ret_260907_mscpmrk-ES_CME_etid8657973&uac=148436CN&impID=8657973

No hay comentarios:

Publicar un comentario